Skip to main content
. 2010;12(5):PCC.09m00883. doi: 10.4088/PCC.09m00883yel

Table 3.

Correlates of Adherence (scale scores entered as dichotomous variables)a

Variable Odds Ratio 95% CI P Value
Lower Limit Upper Limit
Female 0.752 0.542 1.044 .089
Age 0.999 0.985 1.014 .937
White 0.998 0.683 1.459 .993
College graduate* 1.652 1.202 2.270 .002
Alcohol use** 0.521 0.396 0.686 < .001
Body mass index 1.001 0.985 1.017 .922
Comorbid count 1.033 0.930 1.149 .541
SF-8 physical score 0.847 0.631 1.138 .272
No. of depressive episodes 1.001 0.986 1.016 .879
No. of manic episodes 0.993 0.976 1.011 .454
BASIS-24 total score** 0.542 0.403 0.728 < .001
LUNSERS
    Total (excluding red herrings)** 0.597 0.412 0.865 .006
    Red herrings 1.364 0.951 1.957 .092
Satisfaction With Antipsychotic Medication scale* 2.401 1.817 3.172 < .001
Second-generation antipsychotics 1.124 0.836 1.512 .439
Traditional antipsychotics 0.414 0.137 1.247 .117
Mood stabilizers 1.188 0.763 1.849 .447
Selective serotonin reuptake inhibitors 0.953 0.628 1.448 .823
Serotonin-norepinephrine reuptake inhibitors 0.834 0.462 1.504 .546
Dopamine-norepinephrine reuptake inhibitors 1.216 0.711 2.081 .475
Other antidepressants 1.784 0.847 3.757 .128
Sedative hypnotics 0.930 0.522 1.657 .805
Monotherapy use* 1.418 1.025 1.962 .035
a

Method: logistic regression analysis.

*Indicates a positive correlation.

** Indicates a negative correlation.

Abbreviations: BASIS-24 = 24-item Behavior and Symptom Identification Scale, LUNSERS = Liverpool University Neuroleptic Side-Effect Rating Scale, SF-8 = Medical Outcomes Study 8-item Short-Form Health Survey, WPAI = Work Productivity and Activity Impairment.